About us
Collection
For researchers
Subscribe
Our Telegram
Newsletter
About RIMA
For researchers
Collection
Kronika Project
About us
Collection
For researchers
Subscribe
Our Telegram
Parni+
Parni+
Online Media Outlet
Independent source
Found 5 materials
Parni+
·
Jun 6, 2025
Despite pressure: LGBT Pride will still take place in Kyiv
While the police are threatening a “terrorist attack,” LGBTQ activists are preparing for a pride march in Kyiv In recent days, the KyivPride team has been facing serious pressure.
Parni+
·
Jun 6, 2025
“A story of three: how I wanted to be closer to a guy, but I was scared”
A very personal story about desire, confusion and fear. This is a story of teenage intimacy in which everything could be perfect if not for the fear of being yourself. Our author MikraMini recalls what it’s like to experience attraction to a guy at the age of 16, not yet fully aware of yourself or your feelings. “This could be the most romantic first time ever.” It was 2007.
Parni+
·
Jun 6, 2025
Not like everyone else
A story about love and friendship, about devotion and human cruelty, about the injustice of modern realities and the fact that love must certainly win. No matter what. To send us your creativity, contact us via telegram bot @parni_plus_bot . Valya meets Sergei, a classmate of his gay neighbor Roman. Sergei immediately attracts Valya's attention with his bright blue eyes and beautiful smile. However, Valya soon finds out that his new acquaintance prefers girls.
Parni+
·
Jun 6, 2025
Scandalous bisexual Rustam Solntsev became a foreign agent
The Russian Ministry of Justice has updated the list of “foreign agents”. Among the eight new names is Rustam Kalganov, aka Solntsev. The ministry named “gay propaganda” as one of Solntsev’s “foreign agency” arguments. R.P. Kalganov disseminated false information about the decisions taken by public authorities of the Russian Federation and the policies pursued by them. Promoted LGBT relations.
Parni+
·
Jun 6, 2025
Abacavir increased cardiovascular risks in people with HIV
Taking abacavir now or in the past increases the risk of serious adverse cardiovascular events, scientists who analyzed the results of the REPRIEVE study found. Other antiretroviral drugs did not pose this risk. The results of the analysis were published in The Lancet HIV. The study involved 7.7 thousand people with HIV with an average age of 50 years. They were selected for low or moderate risk of cardiovascular disease. 21.9% had ever taken abacavir, 12.6% had it in their current regimen.